bioAffinity Statistics Share Statistics bioAffinity has 938.99K
shares outstanding. The number of shares has increased by 80.75%
in one year.
Shares Outstanding 938.99K Shares Change (YoY) 80.75% Shares Change (QoQ) -1.02% Owned by Institutions (%) 3.15% Shares Floating 772.27K Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 3.33M, so 248.91% of the outstanding
shares have been sold short.
Short Interest 3.33M Short % of Shares Out 248.91% Short % of Float 272.36% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.22 and the forward
PE ratio is -0.36.
bioAffinity's PEG ratio is
0.07.
PE Ratio -1.22 Forward PE -0.36 PS Ratio 1.18 Forward PS 0.4 PB Ratio 4.24 P/FCF Ratio -1.5 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for bioAffinity.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.87,
with a Debt / Equity ratio of 0.58.
Current Ratio 0.87 Quick Ratio 0.86 Debt / Equity 0.58 Debt / EBITDA -0.18 Debt / FCF -0.2 Interest Coverage -96.82
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $164.25K Profits Per Employee $-158.6K Employee Count 57 Asset Turnover 1.44 Inventory Turnover 216.71
Taxes Income Tax 11.65K Effective Tax Rate -0.13%
Stock Price Statistics The stock price has increased by -95.04% in the
last 52 weeks. The beta is 2.54, so bioAffinity's
price volatility has been higher than the market average.
Beta 2.54 52-Week Price Change -95.04% 50-Day Moving Average 7.25 200-Day Moving Average 13.36 Relative Strength Index (RSI) 33.39 Average Volume (20 Days) 1,832,200
Income Statement In the last 12 months, bioAffinity had revenue of 9.36M
and earned -9.04M
in profits. Earnings per share was -22.5.
Revenue 9.36M Gross Profit 3.38M Operating Income -8.95M Net Income -9.04M EBITDA -8.33M EBIT -8.94M Earnings Per Share (EPS) -22.5
Full Income Statement Balance Sheet The company has 1.11M in cash and 1.5M in
debt, giving a net cash position of -395.9K.
Cash & Cash Equivalents 1.11M Total Debt 1.5M Net Cash -395.9K Retained Earnings -53.64M Total Assets 4.75M Working Capital -919.48K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.26M
and capital expenditures -79.08K, giving a free cash flow of -7.34M.
Operating Cash Flow -7.26M Capital Expenditures -79.08K Free Cash Flow -7.34M FCF Per Share -18.16
Full Cash Flow Statement Margins Gross margin is 36.09%, with operating and profit margins of -95.63% and -96.56%.
Gross Margin 36.09% Operating Margin -95.63% Pretax Margin -96.43% Profit Margin -96.56% EBITDA Margin -88.98% EBIT Margin -95.63% FCF Margin -78.44%
Dividends & Yields BIAF does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for BIAF.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 19, 2025. It was a
backward
split with a ratio of 1:30.
Last Split Date Sep 19, 2025 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -24.16 Piotroski F-Score 2
